J Korean Med Sci.  2014 Jan;29(1):32-37. 10.3346/jkms.2014.29.1.32.

Human Papillomavirus Prevalence and Genotype Distribution among HIV-Infected Women in Korea

• Park EK
• Cho H
• Lee SH
• Lee SG
• Lee SY
• Kim KH
• Lee CH
• Chung JS
• Kwak IS

• KMID: 1796911
• DOI: http://doi.org/10.3346/jkms.2014.29.1.32

Abstract

The epidemiology on human papillomavirus (HPV) among human immunodeficiency virus (HIV)-infected women in Korea is not well established. A retrospective study was conducted to determine the prevalence and genotype distribution of HPV infection among HIV-infected women in Korea. HPV DNA genotype and cervical cytology were examined in 60 HIV-positive women and 1,938 HIV-negative women. HPV genotypes were analyzed by using a HPV DNA chip. HIV-infected women had higher prevalence of high-risk HPV (hr-HPV) infection (30% vs 4.9%, adjusted odds ratio [AOR], 6.96; 95% confidence interval [CI], 3.63-13.34, P<0.001) and abnormal cervical cytology (18.3% vs 1.8%, AOR, 10.94; 95% CI, 5.18-23.1, P<0.001) compared with controls. The most common hr-HPV genotype detected in HIV-infected women was HPV 16 (10%), followed by 18 (6.7%) and 52 (5%). Prevalence of quadrivalent vaccine-preventable types (HPV 6, 11, 16, and 18) was 21.7% and 2.3% in HIV-positive women and HIV-negative women, respectively. Age was a significant risk factor for hr-HPV infection in HIV-infected women (P=0.039). The presence of hr-HPV was significantly associated with abnormal cervical cytology (P<0.001). These findings suggest that HPV testing for cervical cancer screening in HIV-infected women would be necessary, particularly among young age group.

Keyword

HIV; Women; Human Papillomavirus; Prevalence; Genotype

MeSH Terms

Adult
Age Factors
Cervix Uteri/virology
DNA Probes, HPV/diagnostic use
DNA, Viral/genetics
Female
Genotype
HIV Infections/complications/*epidemiology/genetics
HIV-1/genetics
Human papillomavirus 11/genetics/isolation & purification
Human papillomavirus 16/genetics/isolation & purification
Human papillomavirus 18/genetics/isolation & purification
Human papillomavirus 6/genetics/isolation & purification
Humans
Middle Aged
Papillomavirus Infections/complications/*epidemiology/*genetics
Prevalence
Republic of Korea/epidemiology
Retrospective Studies
Risk Factors
Uterine Cervical Neoplasms/epidemiology/genetics/virology
DNA Probes, HPV
DNA, Viral

Figure

• 

  Fig. 1 Human papillomavirus (HPV) genotypic distribution in 60 human immunodeficiency virus (HIV)-positive and 1,938 HIV-negative women. U, un-typeable HPV.

Reference

1. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC Jr. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000; 283:1031–1037.

2. Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Touré P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis. 2003; 188:555–563.

3. Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. Clinical Epidemiology Group of the FHDH-ANRS CO4 Cohort. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009; 10:1152–1159.

4. Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, et al. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013; 62:405–413.

5. Lissouba P, Van de Perre P, Auvert B. Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2013; 89:350–356.

6. Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE, Smith JS, Kuhn L, Wang C, Hayes R. Human papillomavirus infection and increased risk of HIV acquisition: a systematic review and meta-analysis. AIDS. 2012; 26:2211–2222.

7. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012; 131:2349–2359.

8. Korea Centers for Disease Control and Prevention. Annual report on the notified HIV/AIDS in Korea. accessed on 1 July 2013. Available at http://stat.mw.go.kr.

9. Shin Y, Kee M. Health care systems in transition II. Korea, part II. the current status of HIV-AIDS in Korea. J Public Health Med. 1998; 20:47–51.

10. Oh MD, Choe K. Epidemiology of HIV infection in the Republic of Korea. J Korean Med Sci. 1999; 14:469–474.

11. Choe PG, Park WB, Song JS, Kim NH, Park JY, Song KH, Park SW, Kim HB, Kim NJ, Oh MD. Late presentation of HIV disease and its associated factors among newly diagnosed patients before and after abolition of a government policy of mass mandatory screening. J Infect. 2011; 63:60–65.

12. Lee JH, Lee EJ, Kim SS, Nam JG, Whang J, Kee MK. Epidemiological characteristics of HIV-infected women in the Republic of Korea: a low HIV prevalence country. J Public Health Policy. 2009; 30:342–355.

13. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41:1–19.

14. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002; 287:2114–2119.

15. Veldhuijzen NJ, Braunstein SL, Vyankandondera J, Ingabire C, Ntirushwa J, Kestelyn E, Tuijn C, Wit FW, Umutoni A, Uwineza M, et al. The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. BMC Infect Dis. 2011; 11:333.

16. Dartell M, Rasch V, Kahesa C, Mwaiselage J, Ngoma T, Junge J, Gernow A, Ejlersen SF, Munk C, Iftner T, et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study. Sex Transm Dis. 2012; 39:201–208.

17. McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA 3rd. Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol. 2010; 116:572–577.

18. Luque AE, Hitti J, Mwachari C, Lane C, Messing S, Cohn SE, Adler D, Rose R, Coombs R. Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). Int J Infect Dis. 2010; 14:e810–e814.

19. Sarkar K, Pal R, Bal B, Saha B, Bhattacharya S, Sengupta S, Mazumdar PP, Chakraborti S. Oncogenic HPV among HIV infected female population in West Bengal, India. BMC Infect Dis. 2011; 11:72.

20. Dols JA, Reid G, Brown JM, Tempelman H, Bontekoe TR, Quint WG, Boon ME. HPV type distribution and cervical cytology among HIV-positive Tanzanian and South African women. ISRN Obstet Gynecol. 2012; 2012:514146.

21. Mane A, Nirmalkar A, Risbud AR, Vermund SH, Mehendale SM, Sahasrabuddhe VV. HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. PLoS One. 2012; 7:e38731.

22. Clifford GM, Shin HR, Oh JK, Waterboer T, Ju YH, Vaccarella S, Quint W, Pawlita M, Franceschi S. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev. 2007; 16:1874–1879.

23. Oh JK, Franceschi S, Kim BK, Kim JY, Ju YH, Hong EK, Chang YC, Rha SH, Kim HH, Kim JH, et al. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea. Eur J Cancer Prev. 2009; 18:56–61.

24. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, Jung KY, Kim HH, Park UD, Cha HS, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer. 2003; 103:413–421.

25. Shin HR, Franceschi S, Vaccarella S, Roh JW, Ju YH, Oh JK, Kong HJ, Rha SH, Jung SI, Kim JI, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis. 2004; 190:468–476.

26. Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M, Williamson AL. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis. 2009; 199:1514–1524.

27. Yun H, Park J, Choi I, Kee M, Choi B, Kim S. Prevalence of human papillomavirus and herpes simplex virus type 2 infection in Korean commercial sex workers. J Microbiol Biotechnol. 2008; 18:350–354.

28. Rhee JE, Shin MY, Kim CM, Kee HY, Chung JK, Min SK, Kim SJ, Jang DH, Kim SS, Choi BS. Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development. Virol J. 2010; 7:201.

29. Kahn JA, Xu J, Kapogiannis BG, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires KE. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis. 2013; 57:735–744.

30. Bridges CB, Woods L, Coyne-Beasley T. Centers for Disease Control and Prevention (CDC), ACIP Adult Immunization Work Group. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older: United States, 2013. MMWR Surveill Summ. 2013; 62:9–19.

31. Lee EH, Um TH, Chi HS, Hong YJ, Cha YJ. Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay. J Korean Med Sci. 2012; 27:1091–1097.